Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: NK-92 cells labeled with Fe3O4-PEG-CD56/Avastin@Ce6 nanoprobes for the targeted treatment and noninvasive therapeutic evaluation of breast cancer

Fig. 6

In vitro therapeutic efficacy. (A) Apoptosis analysis of 4T1 cells after different treatments by FCM analysis. (B) Statistical analysis of cell apoptosis with different group by FCM analysis. (C) Expression of related apoptotic proteins in breast cancer cells after different treatments by western blot analysis. (D) Statistical analysis of cell apoptosis by western blot analysis

Back to article page